Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03108014 · ClinicalTrials.gov registry record

Beginnings Study Follow up

A clinical trial of Healthy, sponsored by Arkansas Children's Hospital Research Institute.

Completed
Registry status
191
Enrollment target
1
Study location

NCT03108014: Completed study of Healthy, sponsored by Arkansas Children's Hospital Research Institute.

NCT03108014 is a study of Healthy that has completed, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 191 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03108014, a study of Healthy, has completed, sponsored by Arkansas Children's Hospital Research Institute.

COMPLETED
Registry status
191 participants
Enrollment target
1
Study location

Study Summary

This study will help us learn more about how early infant diet may influence child's growth and development at age 14.

Primary Outcome

Will be determined with body composition equipment

Conditions Studied

Study Locations (1)

Arkansas

  • Arkansas Children's Nutrition Center - Little Rock

Trial Details

FieldValue
Enrollment Target 191 participants
Start Date 2017-09-17
Est. Completion 2024-07-17

What the finished NCT03108014 record still lists

NCT03108014 is an observational study that tracks outcomes without assigning an intervention. The registered 191 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (70% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 0 interventions.

NCT03108014 reports a single indexed study location in Arkansas.

Frequently Asked Questions

What is clinical trial NCT03108014 about?

NCT03108014 is a clinical study titled "Beginnings Study Follow up". This study will help us learn more about how early infant diet may influence child's growth and development at age 14.

What is the current status of trial NCT03108014?

This trial is currently completed. The enrollment target is 191 participants. The study started on 2017-09-17. Estimated completion is 2024-07-17.

What conditions does trial NCT03108014 study?

This clinical trial studies the following conditions: Healthy.

Who is sponsoring clinical trial NCT03108014?

This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03108014 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03108014's enrollment target sits among peer trials

191 128th of 1090 higher than 963 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04621435 · 191 participants · Phase 1

    Imaging of Solid Tumors Using FAP-2286

  • NCT06810544 · 191 participants · Phase 1

    Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • NCT01492972 · 192 participants · Phase 3

    Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

  • NCT01973881 · 192 participants

    Quantitative MRI for Myelofibrosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03108014, the US trial registry maintained by the National Library of Medicine. NCT03108014 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.